Allergan had a drop in sales to $1,118.7 million for the second quarter of 2009, but this was a 2.2 percent increase in constant currencies. Net earnings rose by 22.9 percent to $176.8 million. For the first half, sales fell by 4.7 percent to $2,113.3 million, with net income dropping ...
Buying a membership today will give you:
To continue reading this article register now.